Results 171 to 180 of about 50,215 (225)

Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer. [PDF]

Breast Cancer Res
Silvestri V, Valentini V, Bucalo A, Porzio V, Scafetta G, Cerbelli B, Zanna I, Bianchi S, Tibiletti MG, Carnevali I, Calistri D, Arcangeli V, Zampiga V, Gasparini E, Cortesi L, Giannini G, Capalbo C, Fox SB, Masala G, Mezi S, d'Amati G, Ottini L.   +21 more
europepmc   +1 more source

Organic acid-based deep eutectic solvents (DESs) are potent antimicrobial agents against antibiotic-resistant bacteria and viruses. [PDF]

Curr Res Microb Sci
Maky MA, Belguesmia Y, Opimba CO, Nekoua MP, Oshinowo T, Tourret M, Boukherroub R, Hober D, Drider D.   +8 more
europepmc   +1 more source

Transcriptionally Informed Nucleosome Profiling of Circulating Cell-Free DNA Predicts Breast Cancer Recurrence. [PDF]

Cancer Res Commun
Watanabe S, Etoh K, Mitsui J, Suzuki Y, Yamamoto Y, Nakao M.   +5 more
europepmc   +1 more source

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study. [PDF]

ESMO Open
Schmidt M, Thill M, Rey J, Rautenberg B, Bjelic-Radisic V, Decker T, Rom J, Kögel M, Lübbe K, Nacke A, Seiler S, Just M, Müller V, Buss-Steidle R, Terhaag J, Mundhenke C, Denkert C, Holtschmidt J, Loibl S.   +18 more
europepmc   +1 more source

Antimicrobial and Synergistic Activity of Metformin Against <i>Helicobacter pylori</i>. [PDF]

Can J Infect Dis Med Microbiol
Rajab WH, Jaradat N, Abdo Q, Aljouda N, Qadi M.   +4 more
europepmc   +1 more source

Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer. [PDF]

Exp Hematol Oncol
Sahin TK, Orhan C, Ozercan IH, Muglu H, Er B, Akyildiz A, Tunbekici S, Oruc A, Aykan MB, Koylu B, Akdogan O, Onur ID, Ates O, Yazici O, Selcukbiricik F, Karadurmus N, Araz M, Erdem D, Goker E, Bilici A, Aksoy S, Guven DC.   +21 more
europepmc   +1 more source

The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis. [PDF]

Medicina (Kaunas)
Toyran T, Bayram E, Aydınalp Camadan Y, Sahin B, Dalcı K, Arslan YK, Ergin M.   +6 more
europepmc   +1 more source

Employment of a Resazurin Viability-Based Assay for Minimum Inhibitory and Bactericidal Concentration Determination. [PDF]

Pharmaceuticals (Basel)
Calvo LG, Corral-Orbe S, Villarino RA, Sánchez S, de Miguel T.   +4 more
europepmc   +1 more source

Metaplastic Breast Carcinoma: Clinicopathological Characteristics, Treatment Patterns, and Outcomes. [PDF]

Cureus
Ara U, Jeelani U, Ara Wani B, Nasreen S, Shenoi LR, Nazir Lone S, Fatima K, Maqsood S, Rashid Guru F, Mir H, Andleeb A.   +10 more
europepmc   +1 more source

Locally advanced breast cancer in an elderly male with end-stage renal disease: A case report. [PDF]

Oncol Lett
Chen M, Feng M, Li X, Wang H, Hong K, Yao C.   +5 more
europepmc   +1 more source